Novo Nordisk (DE:NOV)
XETRA:NOV
Holding DE:NOV?
Track your performance easily

Novo Nordisk (NOV) Technical Analysis

170 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Novo Nordisk’s (NOV) Moving Averages Convergence Divergence (MACD) indicator is -2.47, suggesting Novo Nordisk is a Buy.
Novo Nordisk’s (NOV) 20-Day exponential moving average is 106.73, while Novo Nordisk’s (NOV) share price is €102.52, making it a Sell.
Novo Nordisk’s (NOV) 50-Day exponential moving average is 111.36, while Novo Nordisk’s (NOV) share price is €102.52, making it a Sell.

Novo Nordisk (NOV) Pivot Points

Nov 05, 2024, 07:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
91.68
94.57
98.93
101.82
106.18
109.07
113.43
Fibonacci
94.57
97.34
99.05
101.82
104.59
106.30
109.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NOV) Moving Averages

Nov 05, 2024, 07:22 AM
Period
Simple
Exponential
MA5
103.62Sell
103.73Sell
MA10
105.45Sell
104.93Sell
MA20
106.59Sell
106.73Sell
MA50
113.02Sell
111.36Sell
MA100
119.08Sell
114.65Sell
MA200
117.84Sell
112.37Sell
Novo Nordisk’s (NOV) 10-Day exponential moving average is 104.93, while Novo Nordisk’s (NOV) share price is €102.52, making it a Sell.
Novo Nordisk’s (NOV) 100-Day exponential moving average is 114.65, while Novo Nordisk’s (NOV) share price is €102.52, making it a Sell.
Novo Nordisk’s (NOV) stock price is €102.52 and Novo Nordisk’s (NOV) 50-day simple moving average is 113.02, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €102.52 and Novo Nordisk’s (NOV) 100-day simple moving average is 119.08, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €102.52 and Novo Nordisk’s (NOV) 200-day simple moving average is 117.84, creating a Sell signal.

Novo Nordisk (NOV) Technical Indicators

Nov 05, 2024, 07:22 AM
Name
Value
Implied Action
RSI (14)
31.21
Neutral
STOCH (9,6)
32.90
Neutral
STOCHRSI (14)
28.19
Neutral
MACD (12,26)
-2.47
Buy
ADX (14)
29.50
Neutral
Williams %R
-62.40
Buy
CCI (14)
-147.50
Buy
ATR (14)
2.72
-
Ultimate Oscillator
49.88
Neutral
ROC
-6.28
Sell
Novo Nordisk’s (NOV) Relative Strength Index (RSI) is 31.21, creating a Neutral signal.
Novo Nordisk’s (NOV) Trend Strength Indicator (ADX) is 29.50, creating a Neutral signal.
Novo Nordisk’s (NOV) Commodity Channel Index (CCI) is -147.50, creating a Buy signal.
Novo Nordisk’s (NOV) Price Rate of Change (ROC) is -6.28, creating a Sell signal.

FAQ

Is NOV a Buy, Hold, or Sell?
Based on NOV’s technical indicators, NOV is a Strong Sell.
    What is NOV’s RSI (14)?
    NOV’s RSI (14) is 31.21, which suggests NOV is a Neutral.
      What is NOV’s MACD?
      NOV’s MACD is -2.47, which suggests NOV is a Buy.
        What is NOV’s 5-day moving average?
        NOV’s 5-day moving average is 103.62, which suggests NOV is a Sell.
          What is NOV’s 20-day moving average?
          NOV 20-day moving average is 106.59, which suggests NOV is a Sell.
            What is NOV’s 50-day moving average?
            NOV’s 50-day moving average is 113.02, which suggests NOV is a Sell.
              What is NOV’s 200-day moving average?
              NOV’s 200-day moving average is 117.84, which suggests NOV is a Sell.
                What is NOV’s Williams % R (14)?
                NOV’s Williams % R (14) is -62.40, which suggests NOV is a Buy.
                  What is NOV’s CCI (14)?
                  NOV’s CCI (14) is -147.50, which suggests NOV is a Buy.
                    What is the share price of Novo Nordisk?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis